TotalMarketCap

Market cap

$1.580 B

$13.52 -7.50%

Close of 6 Nov 2026

As of 6 Nov 2026, NovoCure (NVCR) has a market capitalization of $1.58B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$655.4M

#1753 by revenue

Earnings

-$136.2M

Loss-making

Shares outstanding

116,915,959

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #29Lemaitre VascularLMAT$1.90B
  2. #30Kestra Medical TechnologiesKMTS$1.67B
  3. #31NovoCureNVCR$1.58B
  4. #32Tandem Diabetes CareTNDM$1.25B
  5. #33Alpha Tau MedicalDRTS$1.22B

What if NovoCure were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for NovoCure are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.